| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 8.17M | — |
| Operating expense | — | — |
| Net income | -7.42M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BNGO returned -70.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -21.6% |
| 1 year | -70.0% |
| 5 years | -100.0% |
| All-time high | $6,630.00 (Jan 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BNGO would be worth today ›No. Bionano Genomics, Inc. has not paid a dividend in the past 12 months.
Bionano Genomics, Inc. stock trades on NASDAQ under the ticker symbol BNGO.
Bionano Genomics, Inc. is part of the Healthcare sector.
Bionano Genomics, Inc. has a market cap of 14.13M USD, based on the latest quote.
Bionano Genomics, Inc. is scheduled to report earnings on Nov 12, 2026.
